BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8208962)

  • 1. Differentiation of adrenal masses with MR imaging: comparison of techniques.
    Reinig JW; Stutley JE; Leonhardt CM; Spicer KM; Margolis M; Caldwell CB
    Radiology; 1994 Jul; 192(1):41-6. PubMed ID: 8208962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the adrenal gland.
    Boland GW; Lee MJ
    Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
    Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
    AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal masses: characterization with T1-weighted MR imaging.
    Chezmar JL; Robbins SM; Nelson RC; Steinberg HV; Torres WE; Bernardino ME
    Radiology; 1988 Feb; 166(2):357-9. PubMed ID: 3336711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign adrenocortical masses: diagnosis with chemical shift MR imaging.
    Mitchell DG; Crovello M; Matteucci T; Petersen RO; Miettinen MM
    Radiology; 1992 Nov; 185(2):345-51. PubMed ID: 1410337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art MR imaging of the adrenal gland.
    Lee MJ; Mayo-Smith WW; Hahn PF; Goldberg MA; Boland GW; Saini S; Papanicolaou N
    Radiographics; 1994 Sep; 14(5):1015-29; discussion 1029-32. PubMed ID: 7991811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging.
    Tsushima Y; Ishizaka H; Matsumoto M
    Radiology; 1993 Mar; 186(3):705-9. PubMed ID: 8430178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR characterization of adrenal masses: field strength and pulse sequence considerations.
    Kier R; McCarthy S
    Radiology; 1989 Jun; 171(3):671-4. PubMed ID: 2717736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
    Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
    Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The differentiation of adrenal gland tumors: an improvement in accuracy by a combination of fat-sensitive, T2-weighted and contrast-enhanced MR sequences].
    Zimmermann GG; Debatin JF; Krestin GP
    Rofo; 1997 Aug; 167(2):153-9. PubMed ID: 9333356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
    Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
    J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR evaluation of adrenal masses at 1.5 T.
    Baker ME; Blinder R; Spritzer C; Leight GS; Herfkens RJ; Dunnick NR
    AJR Am J Roentgenol; 1989 Aug; 153(2):307-12. PubMed ID: 2750617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
    Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
    AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of chemical shift subtraction MRI in characterization of adrenal masses.
    Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
    AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of parallel acquisition techniques in adrenal magnetic resonance imaging: does increased temporal resolution significantly improve visualization of adrenal lesions?
    Boll DT; Hillenbrand CM; Lewin JS; Merkle EM
    Acad Radiol; 2004 Jul; 11(7):809-16. PubMed ID: 15217599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
    Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of the adrenal.
    Reinig JW; Doppman JL
    Radiologe; 1986 Apr; 26(4):186-90. PubMed ID: 3012628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.